BCMA-directed cell therapy can offer a targeted mechanism of action that modulates myasthenia gravis pathology, Vu noted.

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today presented positive clinical data from a ...

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

These data were presented today during a late-breaking session at the American Heart Association (AHA) Scientific Sessions and published simultaneously in The New England Journal of Medicine (NEJM) in ...

When the usual suspects struggled against upset-conscious Terrafirma, TNT found an unlikely chief gunner in defensive ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...

Kyverna saw an 8-point improvement on the MG-ADL scale, which measures the impact of gMG on daily functions, in the three ...

Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...

The First World War saw millions of soldiers killed and wounded on both sides, and many British troops did something unusual ...

Hundreds of thousands of blood pressure medication pills are being recalled across the United States, according to the Federal Drug Administration. Prazosin Hydrochloride (brand ...